Athira Pharma Inc. (LONA)
Market Closed
16 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary $
5. 20
-0.09
-1.7013%
$
21.26M Market Cap
- P/E Ratio
- Div Yield
61,318 Volume
- Eps
$ 5.29
Previous Close Investors:
Want to track LONA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Athira Pharma Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Curtis Ellergodt Rothschild Investment LLC | 150 | $621 | $808.5 | $187.5 | 30.19% |
 Hui Fai Tam Caitong International Asset Management Co. Ltd. | 6 | $62 | $31.74 | -$30.26 | -48.81% |
 Jim Harding Propel Bio Management LLC | 149,279 | $618,015 | $812,122.54 | $194,107.54 | 31.41% |
 Ian Jameson American Capital Advisory, LLC | 200 | $828 | $1,054 | $226 | 27.29% |
| AH Anders Hove Acorn Capital Advisors LLC | 634,539 | $5.16M | $3.45M | -$1.72M | -33.27% |
2026 © Marketlog. All Rights Reserved.
